A laparoscopic power morcellators is a surgical instrument used in less-invasive abdominal procedures such as laparoscopic hysterectomies and fibroid removal. Use of laparoscopic power morcellators allows for minimally invasive surgical procedures, which, when compared to open abdominal surgery, typically reduce the risk of infection and shorten the post-operative recovery period. However, when used in myomectomy or hysterectomy procedures, there is an increased risk of spreading unsuspected cancer and benign tissue within the abdomen and pelvis. The risk of unsuspected cancer increases with age, particularly in women over 50 years of age. The regulatory authorities have issued safety guidelines for laparoscopic power morcellators market players to be followed while developing devices so that it can minimize the further complications and enhance the research & development activities for upgradation of device.
Market Dynamics
Increasing prevalence of hysterectomy in women is expected to drive the growth of global laparoscopic power morcellators market. For instance, on January 30, 2021, Longitudinal Ageing Study in India (LASI) released data for percentage of women who had undergone hysterectomy among older adult women by in India during 2017-18 which indicates that 12.5% of women aged between 45 and 59, and 9.9% of women aged more than 60. Hence, such growing cases which require hysterectomy is likely to promote the adoption of laparoscopic power morcellators.
In addition, the increasing awareness by regulatory authorities for laparoscopic power morcellators is expected to increase the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on December 29, 2020, the U.S. Food and Drug Administration (FDA) issued labeling guidelines for product to manufacturer of laparoscopic power morcellators to mention the warning on the box of morcellators about risk of cancer infection by using laparoscopic power morcellators which may spread the cancer or decrease the long term survival of patients. Hence, increasing the scope for market players to develop new devices of laparoscopic power morcellators to avoid the risk of cancer.
Key features of the study:
- This report provides an in-depth analysis of global laparoscopic power morcellators market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global laparoscopic power morcellators market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include LiNA Medical, Blue Endo, Johnson and Johnson, Hangzhou Kangji Medical Instruments, WISAP Medical Technology, Zhejiang Geyi Medical Instrument, Karl Storz GmbH, Medtronic, Richard Wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag AG, RUDOLF Medical GmbH, and Olympus Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global laparoscopic power morcellators market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global laparoscopic power morcellators market
Detailed Segmentation:
- Global Laparoscopic Power Morcellators Market, By Application:
- Hysterectomy
- Myomectomy
- Others
- Global Laparoscopic Power Morcellators Market, By End User:
- Hospitals and clinics
- Surgical Centers
- Global Laparoscopic Power Morcellators Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- LiNA Medical*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Blue Endo
- Johnson and Johnson
- Hangzhou Kangji Medical Instruments
- WISAP Medical Technology
- Zhejiang Geyi Medical Instrument
- Karl Storz GmbH
- Medtronic
- Richard Wolf GmbH
- Lumenis (Boston Scientific Corporation)
- Nouvag AG
- RUDOLF Medical GmbH
- Olympus Corporation
“*” marked represents similar segmentation in other categories in the respective section.